#13617
Profile photo of 74
74
Survivalist
rnews

Malgus,

Not so sure about all of your post but this part is right.

Low returns on investments and an unpredictable and often infeasible approval pathway at the U.S. Food and Drug Administration (FDA) have caused many companies to leave the antibiotics market. – See more at: http://www.idsociety.org/10×20/#sthash.nQ50QSVj.dpuf